Standalone figures · ₹ crore · years without a filed annual are summed from quarters
| ₹ Cr | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 62 | 83 | 81 | 85 | 161 | 144 | 133 | 159 | 171 | 184 | 358 | |
| COGS | -22 | — | 31 | 37 | 42 | 50 | 62 | 65 | 59 | 67 | 148 |
| Gross profit | — | — | 49 | 48 | 119 | 93 | 71 | 94 | 112 | 116 | 210 |
| 60 | 53 | 22 | 28 | 67 | 57 | 48 | 53 | 62 | 74 | 93 | |
| 25 | 31 | 27 | 21 | 52 | 36 | 23 | 41 | 50 | 42 | 117 | |
| OPM % | 39.5% | 36.8% | 33.7% | 24.1% | 32.5% | 25.1% | 17.3% | 25.9% | 29.3% | 22.8% | 32.6% |
| Depreciation | — | — | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 4 | 5 |
| Interest | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 2 | 2 | 3 |
| — | — | 1 | 2 | 3 | 5 | 4 | 5 | 7 | 20 | 34 | |
| Profit before tax | 25 | 32 | 26 | 21 | 53 | 38 | 25 | 42 | 53 | 55 | 143 |
| Tax | 9 | 12 | 9 | 6 | 13 | 9 | 7 | 11 | 13 | 14 | 34 |
| Tax % | 35.8% | 36.6% | 34.5% | 27.3% | 24.4% | 24.1% | 29.5% | 25.4% | 24.2% | 25.5% | 24% |
| 16 | 21 | 17 | 15 | 40 | 29 | 17 | 32 | 40 | 41 | 108 | |
| PAT margin % | 25.6% | 24.7% | 21.2% | 17.8% | 24.7% | 20.2% | 13% | 19.8% | 23.3% | 22.3% | 30.3% |
| EPS (₹) | 14.3 | 18.5 | — | — | 29.9 | 21.7 | 13 | 23.7 | 3 | 1.5 | 0.8 |
| EPS adjusted (₹) | — | — | 0.1 | 0.1 | 0.3 | 0.2 | 0.1 | 0.2 | 0.3 | 0.3 | 0.8 |
| Annual report | Annual report for Mar 2016 | Annual report for Mar 2017 | Annual report for Mar 2018 | Annual report for Mar 2019 | Annual report for Mar 2020 | Annual report for Mar 2021 | Annual report for Mar 2022 | Annual report for Mar 2023 | Annual report for Mar 2024 | Annual report for Mar 2025 | — |
| ₹ Cr | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 11 | 13 | 13 | 13 | 13 | 13 | 13 | 27 | 134 |
| Reserves | 55 | 63 | — | 118 | 129 | 154 | 288 | 315 | 316 |
| — | — | — | 0 | 9 | 6 | 12 | 13 | 51 | |
| 13 | 17 | — | 22 | 23 | 16 | 7 | 17 | 52 | |
| Total equity & liabilities | 78 | 93 | — | 152 | 174 | 189 | 320 | 372 | 553 |
| 16 | 21 | 26 | 29 | 31 | 36 | 58 | 67 | 67 | |
| CWIP | — | — | — | 1 | 6 | 0 | 0 | 6 | 25 |
| Investments | 18 | 22 | — | 48 | 54 | 69 | 135 | 103 | 75 |
| 44 | 50 | — | 74 | 84 | 83 | 126 | 196 | 386 | |
| Total assets | 78 | 93 | — | 152 | 174 | 189 | 320 | 372 | 553 |
| ₹ Cr | Mar 2018 | Mar 2019 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| 3 | 18 | 42 | 10 | 33 | 8 | -11 | 46 | |
| -9 | -14 | -9 | -13 | -22 | -80 | 45 | 28 | |
| -3 | -5 | -33 | 3 | -11 | 99 | -1 | 35 | |
| Net cash flow | — | — | 0 | -1 | -0 | 27 | 32 | 110 |
| Free cash flow | 1 | 12 | 38 | 2 | 30 | -82 | -31 | 21 |
| CFO / Operating profit % | 12.6% | 89.4% | 116.3% | 44.6% | 79.2% | 15.7% | -26.7% | 39.5% |
As reported in NSE results XBRL. Segment result is before tax and finance costs.
Latest reported period · 31 Mar 2024 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities |
|---|---|---|---|---|
| Male and Female Contraceptives & Jelly | 163.93 | 46.18 | — | 6.13 |
| Others / Unallocated | 11.06 | 7.29 | — | 0.86 |
| In Vitro Devices (IVD) | 3.32 | -0.89 | — | 0 |
₹ crore by fiscal year